Upgrade to SI Premium - Free Trial

Leerink Partners on Pfizer (PFE): 'positive ruling today should drive additional Comirnaty OUS sales'

April 1, 2026 3:01 PM
Leerink Partners analyst David Risinger reiterated a Market Perform rating and $26.00 price target on Pfizer (NYSE: PFE)The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments